Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 141,789 | 118,316 | 151,890 |
| Marketable Securities | 378,864 | 277,143 | 0 |
| TOTAL | $529,713 | $398,409 | $152,055 |
| Non-Current Assets | |||
| PPE Net | 1,959 | 377 | N/A |
| Investments And Advances | 210,416 | 0 | 0 |
| Other Non-Current Assets | 11,863 | 2,618 | 0 |
| TOTAL | $224,238 | $2,995 | $N/A |
| Total Assets | $753,951 | $401,404 | $152,055 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,071 | 2,143 | 418 |
| Accrued Expenses | 24,255 | 17,314 | 9,562 |
| TOTAL | $28,560 | $20,558 | $9,980 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 8,597 | 933 | 0 |
| TOTAL | $8,597 | $933 | $N/A |
| Total Liabilities | $37,157 | $21,491 | $9,980 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 59,503 | 50,656 | N/A |
| Common Shares | 1 | N/A | 4,393 |
| Retained earnings | -305,916 | -123,770 | -39,785 |
| Other shareholders' equity | 915 | 329 | 0 |
| TOTAL | $716,794 | $379,913 | $142,075 |
| Total Liabilities And Equity | $753,951 | $401,404 | $152,055 |